Page last updated: 2024-10-27

gbr 12935 and Substance Withdrawal Syndrome

gbr 12935 has been researched along with Substance Withdrawal Syndrome in 3 studies

1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimmel, HL1
Carroll, FI1
Kuhar, MJ1
Wilson, JM1
Nobrega, JN1
Carroll, ME1
Niznik, HB1
Shannak, K1
Lac, ST1
Pristupa, ZB1
Dixon, LM1
Kish, SJ1
Hitri, A1
Wyatt, RJ1

Other Studies

3 other studies available for gbr 12935 and Substance Withdrawal Syndrome

ArticleYear
Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:1

    Topics: Animals; Behavior, Animal; Cocaine; Dopamine Plasma Membrane Transport Proteins; Half-Life; In Vitro

2003
Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1994, Volume: 14, Issue:5 Pt 2

    Topics: Animals; Biogenic Monoamines; Brain; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane T

1994
Regional differences in rat brain dopamine transporter binding: function of time after chronic cocaine.
    Clinical neuropharmacology, 1993, Volume: 16, Issue:6

    Topics: Animals; Brain; Brain Chemistry; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Prote

1993